Literature DB >> 15995708

Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis.

Yuya Terashima1, Nobuyuki Onai, Masako Murai, Masahiko Enomoto, Vongsakorn Poonpiriya, Tsuyoshi Hamada, Kazushi Motomura, Makiko Suwa, Taichi Ezaki, Tatsuya Haga, Shiro Kanegasaki, Kouji Matsushima.   

Abstract

Ligation of the chemokine receptor CCR2 on monocytes and macrophages with its ligand CCL2 results in activation of the cascade consisting of phosphatidylinositol-3-OH kinase (PI(3)K), the small G protein Rac and lamellipodium protrusion. We show here that a unique clathrin heavy-chain repeat homology protein, FROUNT, directly bound activated CCR2 and formed clusters at the cell front during chemotaxis. Overexpression of FROUNT amplified the chemokine-elicited PI(3)K-Rac-lamellipodium protrusion cascade and subsequent chemotaxis. Blocking FROUNT function by using a truncated mutant or antisense strategy substantially diminished signaling via CCR2. In a mouse peritonitis model, suppression of endogenous FROUNT markedly prevented macrophage infiltration. Thus, FROUNT links activated CCR2 to the PI(3)K-Rac-lamellipodium protrusion cascade and could be a therapeutic target in chronic inflammatory immune diseases associated with macrophage infiltration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995708     DOI: 10.1038/ni1222

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  40 in total

1.  CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.

Authors:  Emika Toyomitsu; Makoto Tsuda; Tomohiro Yamashita; Hidetoshi Tozaki-Saitoh; Yoshitaka Tanaka; Kazuhide Inoue
Journal:  Purinergic Signal       Date:  2012-01-06       Impact factor: 3.765

2.  Accelerated protein evolution analysis reveals genes and pathways associated with the evolution of mammalian longevity.

Authors:  Yang Li; João Pedro de Magalhães
Journal:  Age (Dordr)       Date:  2011-12-29

3.  The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Authors:  Sarah J Collington; Jenny Hallgren; James E Pease; Tatiana G Jones; Barrett J Rollins; John Westwick; K Frank Austen; Timothy J Williams; Michael F Gurish; Charlotte L Weller
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

Review 4.  Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.

Authors:  Jian Zhang; Lalit Patel; Kenneth J Pienta
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 5.  The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.

Authors:  Élora Midavaine; Jérôme Côté; Philippe Sarret
Journal:  Cancer Metastasis Rev       Date:  2021-05-11       Impact factor: 9.264

6.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

7.  Buprenorphine: Therapeutic potential beyond substance abuse.

Authors:  Stephani Velasquez; Jay Rappaport
Journal:  J Leukoc Biol       Date:  2018-12       Impact factor: 4.962

8.  Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment.

Authors:  Sharon Wei Ling Lee; R J Seager; Felix Litvak; Fabian Spill; Je Lin Sieow; Penny Hweixian Leong; Dillip Kumar; Alrina Shin Min Tan; Siew Cheng Wong; Giulia Adriani; Muhammad Hamid Zaman; And Roger D Kamm
Journal:  Integr Biol (Camb)       Date:  2020-04-20       Impact factor: 2.192

9.  Phosphoproteomic characterization of the signaling network resulting from activation of the chemokine receptor CCR2.

Authors:  Cheng Huang; Simon R Foster; Anup D Shah; Oded Kleifeld; Meritxell Canals; Ralf B Schittenhelm; Martin J Stone
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

10.  Nitrated alpha-synuclein and microglial neuroregulatory activities.

Authors:  Ashley D Reynolds; Irena Kadiu; Sanjay K Garg; Jason G Glanzer; Tara Nordgren; Pawel Ciborowski; Ruma Banerjee; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.